Aptus Capital Advisors LLC Buys 4,770 Shares of Amdocs Limited (NASDAQ:DOX)

Aptus Capital Advisors LLC boosted its stake in shares of Amdocs Limited (NASDAQ:DOX) by 15.4% during the third quarter, Holdings Channel reports. The firm owned 35,766 shares of the technology company’s stock after purchasing an additional 4,770 shares during the quarter. Aptus Capital Advisors LLC’s holdings in Amdocs were worth $3,129,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors have also added to or reduced their stakes in the stock. Ashton Thomas Private Wealth LLC boosted its stake in shares of Amdocs by 21.4% in the 3rd quarter. Ashton Thomas Private Wealth LLC now owns 19,332 shares of the technology company’s stock worth $1,691,000 after buying an additional 3,412 shares during the last quarter. Venturi Wealth Management LLC lifted its holdings in Amdocs by 12.5% in the third quarter. Venturi Wealth Management LLC now owns 11,725 shares of the technology company’s stock valued at $1,026,000 after acquiring an additional 1,305 shares during the period. Crossmark Global Holdings Inc. boosted its position in Amdocs by 34.7% in the third quarter. Crossmark Global Holdings Inc. now owns 145,556 shares of the technology company’s stock worth $12,733,000 after purchasing an additional 37,516 shares during the last quarter. Covestor Ltd grew its stake in shares of Amdocs by 48.4% during the 3rd quarter. Covestor Ltd now owns 2,987 shares of the technology company’s stock valued at $261,000 after purchasing an additional 974 shares during the period. Finally, Atria Investments Inc increased its position in shares of Amdocs by 7.2% during the 3rd quarter. Atria Investments Inc now owns 9,408 shares of the technology company’s stock valued at $823,000 after purchasing an additional 634 shares during the last quarter. Institutional investors own 92.02% of the company’s stock.

Wall Street Analyst Weigh In

Several brokerages recently issued reports on DOX. Stifel Nicolaus assumed coverage on shares of Amdocs in a research report on Wednesday, October 2nd. They set a “buy” rating and a $100.00 target price for the company. Oppenheimer upped their price objective on Amdocs from $98.00 to $105.00 and gave the stock an “outperform” rating in a research note on Wednesday. Finally, StockNews.com upgraded Amdocs from a “buy” rating to a “strong-buy” rating in a research report on Friday, October 25th. One investment analyst has rated the stock with a hold rating, five have given a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Buy” and a consensus target price of $102.50.

Amdocs Stock Down 5.4 %

DOX opened at $87.75 on Thursday. Amdocs Limited has a fifty-two week low of $74.41 and a fifty-two week high of $94.04. The company has a debt-to-equity ratio of 0.21, a quick ratio of 1.24 and a current ratio of 1.24. The stock has a market cap of $10.31 billion, a price-to-earnings ratio of 20.70, a price-to-earnings-growth ratio of 1.50 and a beta of 0.74. The firm’s fifty day moving average is $88.16 and its 200 day moving average is $83.92.

Amdocs Profile

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.